[ad_1]
Britain’s top drug regulator has said that of the 18.1 million people who were inoculated with the Oxford / AstraZeneca needle in the UK, 30 have developed blood clots. In a report published on April 2, the Medicines and Health Products Regulatory Agency (MHRA) also confirmed that seven of the total affected had already died as of March 24. The report is another blow for the Anglo-Swedish pharmaceutical company.
“Our rigorous review of UK reports on rare and specific types of blood clots is ongoing. Through March 24, we have received 22 reports of cerebral venous sinus thrombosis (CVST) and 8 reports of other low platelet thrombosis events, out of a total of 18.1 million doses of the COVID-19 AstraZeneca vaccine administered. Until that date. “The MRHA said in a statement.
The updated data was presented as part of the regulator’s ongoing review of Britain’s COVID-19 vaccines. While MRHA increased the number of clot-related deaths, it clearly stated that there was no evidence to link blood clots to the AstraZeneca / Oxford strokes. In conclusion, they stated, “the benefits of the COVID-19 vaccines continue to outweigh any risks and you should continue to receive your vaccine when invited to do so.”
EU Says ‘No Evidence’ To Restrict AstraZeneca Use
Experts investigating links between the AstraZeneca coronavirus vaccine and blood clots on March 31 said “there is no evidence” to support restricting the use of the vaccine in any population. However, the European Medicines Agency (EMA) also said its safety committee expected to issue an “updated recommendation” on the controversial vaccine after its monthly meeting next week. The EMA statement comes after Germany advised against the use of the AstraZeneca vaccine vaccine for younger people after rare reports of clotting.
On Tuesday, Germany said vaccine injections should not be routinely given to people under the age of 60 due to an increase in reported cases of unusual blood clots in the days after vaccination. EMA Executive Director Emer Cooke said: “Based on current scientific knowledge, there is no evidence to support restricting the use of this vaccine in any population.”
(Image: The Associated Press)
[ad_2]
